Serological assays for SARS-CoV-2 (UA20-226)

University of Arizona inventors have developed a serological assay to test for prior exposure to SARS-CoV-2. This technology uses a two-step protocol to maximize the specificity of the assay and reduce false positives. Background:In November of 2019, a novel coronavirus appeared in Wuhan, China. Since that time, this virus has spread worldwide. It has impacted everything from individuals lives to the worldwide economy. The virus affected many individuals in different ways. There have been individuals with severe symptoms, leading to hospitalization or death, and there have been patients who have not experienced any symptoms at all. This has led to many people wondering if they have been exposed to the virus and developed immunity. This serological test intends to be the most accurate in helping someone determine if they have developed immunity. Learn more at Anne Spieth 520-626-1577

Related Blog

Smart, interactive desk

Get ready to take your space management game to the next level with the University of Glasgow’s innovative project! By combining the

Mechanical Hamstring™

University of Delaware Technology Overview This device was created to allow athletes who suffer a hamstring strain to return to the field

Join Our Newsletter

                                                   Receive Innovation Updates, New Listing Highlights And More